Ryvu Therapeutics S.A announced a private placement of ?20 million in an equity round of funding on November 30, 2022. The transaction include participation from BioNTech SE.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.72 USD | +0.52% | +6.32% | -12.15% |
May. 01 | European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading | MT |
Apr. 25 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
92.72 USD | +0.52% | +6.32% | 22.34B | ||
48.6 PLN | -1.82% | -1.42% | 280M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.15% | 22.34B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- Ryvu Therapeutics S.A. announced that it expects to receive ?20 million in funding from BioNTech SE